![Mohammad Hirmand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammad Hirmand
Direktor/Vorstandsmitglied bei
WHITEHAWK THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Dr. Mohammad Hirmand, MD, ist ein Chief Medical Officer & Executive Vice President bei Turning Point Therapeutics, Inc. Dr. Hirmand war zuvor als Vice President-Clinical Development bei Medivation LLC (Kalifornien), als Associate Director-Clinical Research bei Amgen, Inc., als Senior Director-Clinical Development bei ARCA biopharma, Inc. und als Manager-Market Development & Product Evaluation bei Innoviva, Inc. beschäftigt, ein Senior Director-Clinical Development von Nuvelo, Inc. ein Chief Medical Officer von Peloton Therapeutics, Inc. ein Director-Oncology Development von SuperGen, Inc. ein Principal von Theravance Biopharma US, Inc. und ein Manager-Clinical Data von Tularik, Inc. Er erhielt seinen Bachelor-Abschluss von der Cornell University und einen Doktortitel von der Harvard Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Mohammad Hirmand
| Unternehmen | Position | Beginn |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.03.2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Gründer | 01.08.2022 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mohammad Hirmand
| Unternehmen | Position | Ende |
|---|---|---|
| TURG POIN | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2022 |
| PELOTON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2019 |
| MEDIVATION INC | Geschäftsführer | 01.10.2015 |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Corporate Officer/Principal | - |
| ARCA BIOPHARMA | Corporate Officer/Principal | - |
Ausbildung von Mohammad Hirmand
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
